SUICIDAL THOUGHTS AND BEHAVIORS
See full prescribing information for complete boxed warning.
- TRADE NAMES: Cymbalta (Lilly); Yentreve (Lilly)
- INDICATIONS: Depression
- CLASS: Antidepressant, Noradrenaline reuptake inhibitor, Serotonin reuptake inhibitor
- HALF-LIFE: 8–17 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
5HT1 agonists, Alcohol, Amitriptyline, Artemether/Lumefantrine, Aspirin, Atomoxetine, Cimetidine, Ciprofloxacin, Citalopram, Clomipramine, CYP1A2 inducers, CYP2D6 inhibitors and substrates, Darunavir, Droperidol, Enoxacin, Fesoterodine, Fluoxetine, Fluvoxamine, Iobenguane, Levomepromazine, MAO inhibitors, Meperidine, Moclobemide, Naratriptan, Nebivolol, NSAIDs, Paroxetine Hydrochloride, PEG-Interferon, Quinidine, Sibutramine, SSRIs, St John's Wort, Tamoxifen, Teriflunomide, Thioridazine, Tramadol, Tricyclic antidepressants, Tryptophan, Venlafaxine, Viloxazine, Warfarin
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of duloxetine in the Informa Healthcare journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 12/14/2024
